We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK. MHRA is an executive agency, sponsored by the Department of Health and Social Care .
How to use an ethnographic study to evaluate your digital health product.
How the MHRA makes decisions on what is a medicinal product (borderline products).
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
How to begin with evaluating a digital health product, including when to evaluate, budgeting and getting support.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Competent authorities of exporting countries should use the relevant model health certificate as a template to create a version exporters can apply for to export other animal products to Great Britain, the Channel Islands or Isle of Man.
The requirements for 3D printed products will depend on whether they are classed as medical devices, personal protective equipment (PPE) or both.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
How to access social care, and support if you, or someone you care for is blind.
Information on how to request assistance from NSDR.
How to use a cost utility analysis to evaluate your digital health product.
How to use a cost consequence analysis to evaluate your digital health product.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
Why it's important to evaluate digital health products that have been developed rapidly and how to choose evaluation methods in these circumstances.
How to import plants, fruit, vegetables, cut flowers, trees, seeds and used agricultural machinery from non-EU countries to Great Britain (England, Scotland and Wales).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.